US FDA’s COVID Master Protocol Guidance To Maintain Influence Post-Pandemic

 
• By Derrick Gingery
  
Clinical research
Drugs evaluated in a master protocol are expected to have already been tested in humans, the FDA said in the guidance. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D